Franklin Street Advisors Inc Curis Inc Transaction History

Franklin Street Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$0.57 - $0.99 $28,499 - $49,500	50,000 Added 48.76%	152,550 $127,000
Q3 2022 Oct 11, 2022	BUY	$0.74 - $15.01 $37,000 - $750,500	50,000 Added 95.15%	102,550 $72,000
Q4 2021 Jan 26, 2022	BUY	$4.45 - $8.09 $5,117 - $9,303	1,150 Added 2.24%	52,550 $250,000
Q3 2021 Oct 22, 2021	BUY	$6.94 - $8.85 $79,116 - $100,890	11,400 Added 28.5%	51,400 $402,000
Q2 2021 Aug 05, 2021	BUY	$7.45 - $16.27 $149,000 - $325,400	20,000 Added 100.0%	40,000 $323,000
Q1 2021 May 04, 2021	BUY	$8.78 - $12.8 $175,600 - $256,000	20,000 New	20,000 $226,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Franklin Street Advisors Inc with notifications on news.